Mario Sousa-Fontes

Lisbon, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Plain language summary about how patients with HER2 positive breast cancer across Europe feel about their cancer, treatment, and future health and related implications for their treatment journey.

Plain language summary about how patients with HER2 positive breast cancer across Europe feel about their cancer, treatment, and future health and related implications for their treatment journey.

Journal: Future oncology (London, England)

Published: May 13, 2026

Central nervous system and leptomeningeal metastases in patients with HER2-positive breast cancer: A comprehensive review and therapeutic algorithm proposal.

Central nervous system and leptomeningeal metastases in patients with HER2-positive breast cancer: A comprehensive review and therapeutic algorithm proposal.

Journal: Cancer treatment reviews

Published: March 12, 2026

Age and Clinical Outcomes of Immune Checkpoint Inhibitor Toxicities in Portugal: A Decade of Pharmacovigilance.

Age and Clinical Outcomes of Immune Checkpoint Inhibitor Toxicities in Portugal: A Decade of Pharmacovigilance.

Journal: Cancers

Published: December 06, 2025

Corrigendum to 'Stauffer's syndrome: A comprehensive review and proposed updated diagnostic criteria' [Urologic Oncology: Seminars and Original Investigations Volume 36, Issue 7 (2018) 321-326].

Corrigendum to 'Stauffer's syndrome: A comprehensive review and proposed updated diagnostic criteria' [Urologic Oncology: Seminars and Original Investigations Volume 36, Issue 7 (2018) 321-326].

Journal: Urologic oncology

Published: October 09, 2025

Adjuvant treatment preferences in high-risk upper tract urothelial carcinoma: the perspective of Portuguese medical oncologists.

Adjuvant treatment preferences in high-risk upper tract urothelial carcinoma: the perspective of Portuguese medical oncologists.

Journal: The oncologist

Published: August 18, 2025

Brain imaging screening in metastatic breast cancer: patients' and physicians' perspectives.

Brain imaging screening in metastatic breast cancer: patients' and physicians' perspectives.

Journal: Breast (Edinburgh, Scotland)

Published: August 07, 2025

Cognitive Impairment in Prostate Cancer Patients Receiving Androgen Deprivation Therapy: A Scoping Review.

Cognitive Impairment in Prostate Cancer Patients Receiving Androgen Deprivation Therapy: A Scoping Review.

Journal: Cancers

Published: June 09, 2025

Current status of adjuvant immunotherapy and relapse management in renal cell carcinoma: Insights from a European delphi study.

Current status of adjuvant immunotherapy and relapse management in renal cell carcinoma: Insights from a European delphi study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 21, 2025

Exploring the integration of patient-reported outcome measures in clinical practice: A cross-sectional survey of EORTC healthcare professionals.

Exploring the integration of patient-reported outcome measures in clinical practice: A cross-sectional survey of EORTC healthcare professionals.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 16, 2025

Towards a Consensus on the Management of Metastatic Renal Cell Carcinoma: Insights from a European Delphi Study.

Towards a Consensus on the Management of Metastatic Renal Cell Carcinoma: Insights from a European Delphi Study.

Journal: European urology oncology

Published: October 11, 2024

Patient perception on risk of recurrence and decision-making in the management of HER2-positive early breast cancer: Insights from the ASKHER2 European survey.

Patient perception on risk of recurrence and decision-making in the management of HER2-positive early breast cancer: Insights from the ASKHER2 European survey.

Journal: Breast (Edinburgh, Scotland)

Published: June 20, 2024

Case report: Primary CDK4/6 inhibitor and endocrine therapy in locally advanced breast cancer and its effect on gut and intratumoral microbiota.

Case report: Primary CDK4/6 inhibitor and endocrine therapy in locally advanced breast cancer and its effect on gut and intratumoral microbiota.

Journal: Frontiers in oncology

Published: December 24, 2023

Showing 1-12 of 26

Last Updated: 09/26/2026